Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
889
datasets available to search
ShareScore release 0.9.0
Dataset results
889 results for “fatty liver”
Validity of Laboratory Biomarkers in Diagnosis of Nonalcoholic Fatty Liver Disease (NAFLD) and It's Consequences
ClinicalTrials.gov study NCT06908122. IPD Sharing: NO. Countries: 0. Publications: 5.
To Explore the Value of New MR Technology in Non-invasive Quantitative Assessment of Systemic Metabolism, Disease Status and Prognosis in Patients With Metabolic-Associated Fatty Liver Disease
ClinicalTrials.gov study NCT07149571. IPD Sharing: NO. Countries: 1. Publications: 0.
Portal Hypertension in Non-alcoholic Fatty Liver Disease: Association With Cardiovascular Risk and Identification of Non-invasive Biomarkers (THESIS)
ClinicalTrials.gov study NCT04191044. IPD Sharing: Not stated. Countries: 0. Publications: 4.
Obesity and Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT00262964. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy of Sodium Glucose Cotransporter 2 Inhibitors on Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06739486. IPD Sharing: Not stated. Countries: 0. Publications: 13.
Effect of Supplementation of Fish Oil on Non-alcoholic Fatty Liver Disease in Children
ClinicalTrials.gov study NCT01547910. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Effect of Probiotics in Non-alcoholic Fatty Liver Disease and Steatohepatitis
ClinicalTrials.gov study NCT04175392. IPD Sharing: NO. Countries: 1. Publications: 0.
Adding Exenatide to Insulin Therapy for Patients With Type 2 Diabetes and Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01006889. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study to Investigate the Effects of Different Doses of S-adenosyl-L-methionine (SAMe) in Subjects With Nonalcoholic Fatty Liver Disease and Non-treated Matched Healthy Volunteers as Control Group
ClinicalTrials.gov study NCT01754714. IPD Sharing: Not stated. Countries: 4. Publications: 0.
Transient Elastograghy to Detect Non Alcoholic Fatty Liver Disease in Renal Transplantation Recipients.
ClinicalTrials.gov study NCT05894993. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Use of a Novel Drug in People With Non-alcoholic Steatohepatitis (NASH) or Non-alcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT02605616. IPD Sharing: NO. Countries: 1. Publications: 0.
Rifaximin in Fatty Liver Disease
ClinicalTrials.gov study NCT01355575. IPD Sharing: NO. Countries: 1. Publications: 0.
Quantitative Ultrasound With Liver Incytes for Evaluation of Non-Alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT04576923. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Metformin for the Treatment of Nonalcoholic Fatty Liver Disease (NAFLD)
ClinicalTrials.gov study NCT00736385. IPD Sharing: Not stated. Countries: 1. Publications: 0.
The Role of Obstructive Sleep Apnea in Children With Fatty Liver Disease
ClinicalTrials.gov study NCT02134522. IPD Sharing: NO. Countries: 1. Publications: 0.
Structured Mobile Technology Based Lifestyle Program vs Usual Care for Patients With Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT03839082. IPD Sharing: NO. Countries: 1. Publications: 0.
Nonalcoholic Fatty Liver Disease in Morbidly Obese Patients
ClinicalTrials.gov study NCT04059029. IPD Sharing: NO. Countries: 0. Publications: 7.
Effect of Phytosterols on Nonalcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT01875978. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Test How Well Different Doses of BI 3006337 Are Tolerated by People With Overweight or Obesity and With Fatty Liver Disease
ClinicalTrials.gov study NCT05970640. IPD Sharing: NO. Countries: 1. Publications: 0.
Tocotrienol as a Treatment for Non-alcoholic Fatty Liver Disease
ClinicalTrials.gov study NCT06596382. IPD Sharing: NO. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.